Lai Chong, Jin Ren-an, Liang Xiao, Cai Xiu-jun
Department of Surgery, Institute of Minimally Invasive Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China.
Department of Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
J Zhejiang Univ Sci B. 2016 Mar;17(3):236-46. doi: 10.1631/jzus.B1500322.
Three mainstream techniques--laparoscopic hepatectomy (LH), percutaneous radiofrequency ablation (pRFA), and open hepatectomy (OH)--were compared in this study, in terms of their efficacies in the treatment of small hepatocellular carcinoma (HCC).
A comparative study was performed within a total of 94 patients diagnosed with small HCC in our hospital from 2005 to 2010, who underwent LH (28), RFA (33), or OH (33). They had either a single tumor lesion of less than or up to three nodules with diameters of less than each. Outcomes were carefully evaluated throughout a 3-year follow-up interval and statistically interpreted.
The pRFA group had a significantly lower disease-free survival rate compared with the two surgical groups (P=0.001) and significantly shorter overall survival (P=0.005), while the LH group and the OH group had no difference in survival results. For patients younger than 60 years old, surgical approaches offered a better long-term overall survival prognosis (P=0.008). There were no statistically significant differences among the three groups in overall survival for elderly patients (P=0.104).
Among patients with small HCC, LH may provide better curative effects than pRFA without increasing complication rates. pRFA leads to faster recurrence than surgical resections. LH has similar therapeutic effects to OH and causes less trauma. For patients younger than 60 years old, LH may be the best curative treatment. Elderly patients may choose either surgery or pRFA.
本研究比较了三种主流技术——腹腔镜肝切除术(LH)、经皮射频消融术(pRFA)和开放性肝切除术(OH)治疗小肝细胞癌(HCC)的疗效。
对2005年至2010年在我院确诊为小HCC并接受LH(28例)、RFA(33例)或OH(33例)的94例患者进行了一项对比研究。他们均为单个肿瘤病灶或直径小于3个结节且每个结节直径均小于相应标准。在3年的随访期内对结果进行了仔细评估并进行统计学分析。
与两个手术组相比,pRFA组的无病生存率显著较低(P = 0.001),总生存期显著较短(P = 0.005),而LH组和OH组的生存结果无差异。对于年龄小于60岁的患者,手术治疗提供了更好的长期总生存预后(P = 0.008)。老年患者三组间总生存期无统计学显著差异(P = 0.104)。
在小HCC患者中,LH可能比pRFA提供更好的疗效且不增加并发症发生率。pRFA比手术切除导致更快的复发。LH与OH具有相似的治疗效果且创伤较小。对于年龄小于60岁的患者,LH可能是最佳的治疗方法。老年患者可选择手术或pRFA。